Drivers and Implications of Multi-Billion Dollar Acquisitions in Medtech
Drivers and Implications of Multi-Billion Dollar Acquisitions in Medtech After a busy 2021, medical technology (medtech) mergers and acquisitions (M&As) dropped in 2022 largely due to the impacts of COVID-19, rising inflation and supply chain challenges. But some medtech companies were able to launch megadeals in 2022 despite macroeconomic conditions.[1] While billion-dollar deals are …
Drivers and Implications of Multi-Billion Dollar Acquisitions in Medtech Read More »